N/A N=198 Randomized Treatment

Financial Incentives for Smoking Cessation Among Mothers

Cigarette Smoking

Bottom Line

View on ClinicalTrials.gov: NCT05740098 ↗

Enrolled (actual)

198

Serious AEs

0.5%

Results posted

Jul 2023

Primary outcome: Primary: 7-day Point Prevalence Smoking Abstinence Levels — 4; 22; 18; 6 Participants — p=<0.001

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Best Practices (Behavioral); Financial Incentives (Behavioral); Nicotine Replacement Therapy (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: Female
Sponsor: University of Vermont
Primary completion: Dec 2019

Outcome Measures

Outcome	Result	p-value
PRIMARY 7-day Point Prevalence Smoking Abstinence Levels	4; 22; 18; 6; 14; 12	<0.001 sig
PRIMARY Objective Measure of Child Secondhand Smoke Exposure (SHSe)	3.53; 3.48; 8.49	0.287
SECONDARY Continuous Abstinence	3; 12; 10	0.009 sig
SECONDARY 7-day Point Prevalence Abstinence at 48-week Follow-up Assessment	5; 11; 6	0.145
SECONDARY Smoking Abstinence	49; 44; 32; 22	0.302
SECONDARY Smoking Abstinence	49; 44; 32; 22	0.302

Summary

Investigators will examine whether adding financial incentives and nicotine replacement dual therapy to current best practices for smoking cessation (i.e. referral to counseling using a telephone quit line) increases cessation rates in mothers and reduces second-hand smoke exposure in children. While perhaps more expensive upfront compared to best practices alone, the investigators hypothesize that this treatment approach will be a more cost-effective cessation intervention.

Eligibility Criteria

Inclusion Criteria

Expresses interest in quitting smoking
Express willingness to initiate NRT
Mother is ≥ 18 years of age
Self-reported smoking ≥ 10 cigarettes per day for ≥ 1 year, biochemically verified
Mother has a child < 12 years of age
Child resides with mother full-time
Not currently using any other tobacco cessation medications (e.g. Chantix) or NRT, or willing to stop use prior to participation in the study
Lives in Chittenden County, Vermont or surrounding counties
Plans on remaining in the geographical area for the next 12 months
English-speaking
Willing to let child participate in the study

Exclusion Criteria

Failing to meet any of the above criteria
Has medical contraindications to NRT products
Meeting Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for moderate or severe alcohol or drug dependence other than nicotine in the prior 12 months (those on opioid substitution therapy are allowed)
Current/past psychotic disorder
Being suicidal
Currently pregnant or trying to become pregnant in the next 12 months
Incarceration
Refusal to participate in study

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05740098). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.